Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rare sugar complex (RSC) is a combination of several monosaccharides classified as "rare sugars," which are naturally occurring sugars present in very limited quantities in nature. The typical formulation of RSC includes L-arabinose, D-mannose, D-xylose, D-allulose, and D-tagatose. These sugars have unique chemical structures compared to common dietary sugars and are being studied for their potential health benefits. Mechanistically, the components of RSC may exert beneficial effects through multiple pathways: - Modulation of glycemic response by inhibiting carbohydrate digestion or absorption. - Antioxidant activity (e.g., increased superoxide dismutase activity). - Reduction of oxidative stress markers such as malondialdehyde. - Modulation of gut microbiota composition. Preclinical studies suggest that RSC can alleviate cognitive impairment associated with type 2 diabetes mellitus by reducing cerebral oxidative stress and restoring gut microbiome diversity. Individual rare sugars within the complex have also been shown to influence weight management and glycemic control[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rare sugar complex.